Titan Treats First Parkinson’s Patient with Ropinirole Implant in Clinical Trial — Fun Health

The first patient has been treated in a clinical trial evaluating Titan Pharmaceuticals’ ropinirole implants, designed to treat the signs and symptoms of Parkinson’s disease. The Phase 1/2 study (NCT03250117) is taking place at three clinical sites in the U.S. that specialize in Parkinson’s research. Researchers expect to enroll 20 Parkinson’s patients who are currently taking oral ropinirole (Requip, manufactured by…

via Titan Treats First Parkinson’s Patient with Ropinirole Implant in Clinical Trial — Fun Health

Categories: parkinson's disease

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s